Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing
Syndicate includes leading UK investors Amadeus Capital Partners,…
Optimum Strategic Communications Expands Team with Appointment of Shabnam Bashir
08 January 2020, London, UK: Optimum Strategic Communications…
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:…
Edinburgh Molecular Imaging Closes Financing
To accelerate development of molecular targeted systemic radiotherapy…
Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company
Forendo Pharma, a clinical stage drug development company focusing…
STORM Therapeutics’ collaborator awarded ASH–BSH Abstract Achievement Award at the 61st ASH Annual Meeting & Exposition
09 December 2019, Cambridge, UK: STORM Therapeutics, the biotechnology…
ImaginAb Initiates Phase II Clinical Trial at Penn Medicine
LOS ANGELES, Dec. 9, 2019 /PRNewswire/ -- ImaginAb Inc., a clinical-stage…
Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home
Enzyre, which is developing breakthrough ambulant diagnostic…
IXICO to Present Abstracts at Upcoming Clinical Trials on Alzheimer’s Disease Congress
IXICO plc (AIM: IXI), the AI data analytics company delivering…
Owkin Teams up with NVIDIA and King’s College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning
PARIS and NEW YORK, Dec. 2, 2019 /PRNewswire/ -- Owkin, which…
European CNS Specialist Neuraxpharm Expands Southern European Presence with Expansion into Portugal
LANGENFELD, Germany, Nov. 28, 2019 /PRNewswire/…
Novo Seeds expands company formation activities at BiOrigin with seasoned entrepreneurs
Date: November 26, 2019
Location: Copenhagen
Martin…
IXICO Notice of Results
IXICO plc (AIM: IXI), the AI data analytics company delivering…
Azeria Therapeutics announces £32.0 million series B financing
Syncona leads £32.0 million Series B financing of Azeria…
Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data Platform
Industry veterans including Craig Lipset will support Castor’s…
Theragnostics strengthens leadership team with two key appointments
Chris Sterling appointed as Non-Executive Director & Radiopharmaceutical…
Calliditas Interim Report Q3, 2019
Positive Regulatory Outcome – Enhanced study design
“This…
F2G Receives US FDA Breakthrough Therapy Designation for Olorofim
In Phase 2b development for the treatment of life-threatening…
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
CAMBRIDGE, England and HOUSTON and SOUTH SAN FRANCISCO, Calif., Nov.…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York